SCHEMBL19863031

SCHEMBL19863031

c1ccc(-c2nc(-c3ccccc3)nc(-n3c4ccccc4c4c(-c5ccc(-c6ccc7c8ccccc8c8ccccc8c7c6)cc5)cc5c6ccccc6oc5c43)n2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.34
TSHR P16473 4/20 0.33
ALDH1A1 P00352 4/20 0.33
LMNA P02545 4/20 0.33
KDM4E B2RXH2 3/20 0.33
HSD17B10 Q99714 2/20 0.33
POLB P06746 2/20 0.33
MAPK1 P28482 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
PLA2G2A P14555 1/20 0.32
PLA2G4A P47712 1/20 0.32
PIM1 P11309 1/20 0.32
CSNK2A2 P19784 1/20 0.32
CSNK2B P67870 1/20 0.32
PIM3 Q86V86 1/20 0.32
PIM2 Q9P1W9 1/20 0.32
HPGD P15428 1/20 0.31
KMT2A Q03164 2/20 0.31
MEN1 O00255 1/20 0.31
USP2 O75604 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19863030 0.97 MAPT (0.34) MAPTTSHRALDH1A1LMNAKDM4E
SCHEMBL19863024 0.96 MAPT (0.34) MAPTTSHRALDH1A1LMNAKDM4E
SCHEMBL19863034 0.95 ALOX5 (0.33) MAPTTSHRALDH1A1LMNAKDM4E
SCHEMBL19863060 0.95 MAPT (0.36) MAPTTSHRALDH1A1LMNAKDM4E
SCHEMBL18594352 0.94 MAPT (0.37) MAPTTSHRALDH1A1LMNAKDM4E
SCHEMBL18594417 0.93 MAPT (0.38) MAPTTSHRALDH1A1LMNAKDM4E
SCHEMBL19863032 0.92 MAPT (0.34) MAPTTSHRALDH1A1LMNAKDM4E
SCHEMBL19863022 0.91 MAPT (0.34) MAPTTSHRALDH1A1LMNAKDM4E
SCHEMBL19863001 0.91 KDM4E (0.33) MAPTTSHRALDH1A1LMNAKDM4E
SCHEMBL19862998 0.91 KDM4E (0.33) MAPTTSHRALDH1A1LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 MAPT 746/4885TSHR 3741/4885ALDH1A1 242/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 MAPT 746/4885TSHR 3741/4885ALDH1A1 242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.